Quick answers
- What is JORNAY PM Extended-Release?
- JORNAY PM Extended-Release is a brand name of Methylphenidate, a prescription medicine. The FDA NDC Directory lists 5 JORNAY PM Extended-Release products in 5 strengths and forms.
- Who makes JORNAY PM Extended-Release?
- Ironshore Pharms holds the FDA application for JORNAY PM Extended-Release (NDA209311, approved August 8, 2018).
- Is there a generic or store brand of JORNAY PM Extended-Release?
- Other products of Methylphenidate are listed with the FDA, but none in exactly the same strength and form as a JORNAY PM Extended-Release product.
- What do pharmacies pay for JORNAY PM Extended-Release?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 5 JORNAY PM Extended-Release strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has JORNAY PM Extended-Release been recalled?
- No recall linked to JORNAY PM Extended-Release products (by their NDC code or label) appears in the FDA enforcement reports we use.
What JORNAY PM Extended-Release is
Each JORNAY PM Extended-Release product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Methylphenidate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| methylphenidate hydrochloride 100 mg capsule (oral) | JORNAY PM Extended-Release | None listed | DailyMed |
| methylphenidate hydrochloride 20 mg capsule (oral) | JORNAY PM Extended-Release | None listed | DailyMed |
| methylphenidate hydrochloride 40 mg capsule (oral) | JORNAY PM Extended-Release | None listed | DailyMed |
| methylphenidate hydrochloride 60 mg capsule (oral) | JORNAY PM Extended-Release | None listed | DailyMed |
| methylphenidate hydrochloride 80 mg capsule (oral) | JORNAY PM Extended-Release | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Methylphenidate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA209311 | Ironshore Pharms | August 8, 2018 | 5 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| methylphenidate hydrochloride 100 mg capsule | Brand: JORNAY PM Extended-Release | $15.38 per capsule |
| methylphenidate hydrochloride 20 mg capsule | Brand: JORNAY PM Extended-Release | $15.38 per capsule |
| methylphenidate hydrochloride 40 mg capsule | Brand: JORNAY PM Extended-Release | $15.41 per capsule |
| methylphenidate hydrochloride 60 mg capsule | Brand: JORNAY PM Extended-Release | $15.40 per capsule |
| methylphenidate hydrochloride 80 mg capsule | Brand: JORNAY PM Extended-Release | $15.40 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list JORNAY PM Extended-Release
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of JORNAY PM Extended-Release products.
- Ironshore Pharmaceuticals Inc.5 products
Recalls
No recall linked to JORNAY PM Extended-Release products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.